Chlor-Trimeton Syrup

Pronunciation: klor-fen-IHR-ah-meen
Generic Name: Chlorpheniramine
Brand Name: Examples include Aller-Chlor and Chlor-Trimeton

Chlor-Trimeton Syrup is used for:

Relieving symptoms of sinus congestion, sinus pressure, runny nose, watery eyes, itching of the nose and throat, and sneezing due to upper respiratory infections (eg, colds), allergies, and hay fever. It may also be used for other conditions as determined by your doctor.

Chlor-Trimeton Syrup is an antihistamine. It works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing.

Do NOT use Chlor-Trimeton Syrup if:

• you are allergic to any ingredient in Chlor-Trimeton Syrup


• you are taking sodium oxybate (GHB) or if you have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Chlor-Trimeton Syrup:

Some medical conditions may interact with Chlor-Trimeton Syrup. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, plan to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a fast, slow, or irregular heartbeat


• if you have a history of asthma, lung problems (eg, emphysema), heart problems, high blood pressure, diabetes, heart blood vessel problems, stroke, glaucoma, a blockage of your stomach or intestines, ulcers, a blockage of your bladder, trouble urinating, an enlarged prostate, seizures, or an overactive thyroid

Some MEDICINES MAY INTERACT with Chlor-Trimeton Syrup. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Furazolidone, MAO inhibitors (eg, phenelzine), sodium oxybate (GHB), or tricyclic antidepressants (eg, amitriptyline) because side effects of Chlor-Trimeton Syrup may be increased


• Hydantoins (eg, phenytoin) because side effects may be increased by Chlor-Trimeton Syrup

This may not be a complete list of all interactions that may occur. Ask your health care provider if Chlor-Trimeton Syrup may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Chlor-Trimeton Syrup:

Use Chlor-Trimeton Syrup as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Chlor-Trimeton Syrup may be taken with or without food.


• Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.


• If you miss a dose of Chlor-Trimeton Syrup, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Chlor-Trimeton Syrup.

Important safety information:

• Chlor-Trimeton Syrup may cause dizziness, drowsiness, or blurred vision. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Chlor-Trimeton Syrup. Using Chlor-Trimeton Syrup alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.


• Do NOT exceed the recommended dose or take Chlor-Trimeton Syrup for longer than prescribed without checking with your doctor.


• If your symptoms do not improve within 5 to 7 days or if they become worse, check with your doctor.


• Chlor-Trimeton Syrup may cause increased sensitivity to the sun. Avoid exposure to the sun, sunlamps, or tanning booths until you know how you react to Chlor-Trimeton Syrup. Use a sunscreen or protective clothing if you must be outside for a prolonged period.


• If you are scheduled for allergy skin testing, do not take Chlor-Trimeton Syrup for several days before the test because it may decrease your response to the skin tests.


• Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Chlor-Trimeton Syrup.


• Use Chlor-Trimeton Syrup with caution in the ELDERLY because they may be more sensitive to its effects.


• Caution is advised when using Chlor-Trimeton Syrup in CHILDREN because they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Chlor-Trimeton Syrup, discuss with your doctor the benefits and risks of using Chlor-Trimeton Syrup during pregnancy. It is unknown if Chlor-Trimeton Syrup is excreted in breast milk. Do not breast-feed while taking Chlor-Trimeton Syrup.

Possible side effects of Chlor-Trimeton Syrup:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dizziness; drowsiness; dry mouth, nose, or throat; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor; trouble sleeping; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Chlor-Trimeton side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; and vomiting.

Proper storage of Chlor-Trimeton Syrup:

Store Chlor-Trimeton Syrup at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Chlor-Trimeton Syrup out of the reach of children and away from pets.

General information:

• If you have any questions about Chlor-Trimeton Syrup, please talk with your doctor, pharmacist, or other health care provider.


• Chlor-Trimeton Syrup is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Chlor-Trimeton Syrup. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Chlor-Trimeton resources

• Chlor-Trimeton Side Effects (in more detail)
• Chlor-Trimeton Use in Pregnancy & Breastfeeding
• Chlor-Trimeton Drug Interactions
• Chlor-Trimeton Support Group
• 9 Reviews for Chlor-Trimeton - Add your own review/rating

Compare Chlor-Trimeton with other medications

• Allergic Reactions
• Cold Symptoms
• Hay Fever
• Urticaria

chymopapain Injection

kye-moe-pa-PAY-in

Commonly used brand name(s)

In Canada

• Chymodiactin

Available Dosage Forms:

• Powder for Solution

Therapeutic Class: Gastrointestinal Agent

Pharmacologic Class: Proteolytic Enzyme

Uses For chymopapain

Chymopapain is injected directly into a herniated ("slipped'') disk in the spine to dissolve part of the disk and relieve the pain and other problems caused by the disk pressing on a nerve. Before you receive chymopapain, you will be given an anesthetic (either a general anesthetic to put you to sleep or a local anesthetic).

Very rarely, use of chymopapain may cause serious side effects, including paralysis of the legs or death. Another dangerous side effect of chymopapain injection is a severe allergic reaction called anaphylaxis. This side effect occurs in less than 1% of the patients receiving the medicine, but it occurs more often in women than in men. Before receiving chymopapain, you should discuss its use, and the possibility of anaphylaxis or other serious side effects, with your doctor.

Chymopapain injections are given only in a hospital, usually in an operating room, by your surgeon.

chymopapain was available only with your doctor's prescription.

The sale and distribution of chymopapain was discontinued in the US in January 27, 2003 .

Before Using chymopapain

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For chymopapain, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to chymopapain or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Studies on chymopapain have been done only in adult patients, and there is no specific information comparing use of chymopapain in children with use in other age groups.

Geriatric

Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of chymopapain in the elderly with use in other age groups.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of chymopapain. Make sure you tell your doctor if you have any other medical problems, especially:

• Allergic reaction to papaya or


• Previous chymopapain injection—Increased risk of serious allergic reactions.

• Diseases of the back (spine), muscles, or nerves or


• High blood pressure (hypertension) or


• Stroke or bleeding in the brain (or if any member of your family has ever had these problems) or


• Surgery of the back—The chance of side effects may be increased.

Proper Use of chymopapain

Dosing

The dose of chymopapain will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of chymopapain. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

chymopapain Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Very rarely, use of chymopapain has caused serious side effects, including paralysis of the legs or death. Also, chymopapain may cause dangerous allergic reactions, especially in women.

Check with your doctor as soon as possible if any of the following side effects occur:

Rare

• Abdominal or stomach cramps or pain


• changes in facial skin color


• constipation (severe)


• convulsions (seizures)


• decreased or uncontrolled urination


• fast or irregular breathing


• headache (sudden, severe, and continuing)


• hot skin


• pain, tenderness, swelling and/or skin color changes of the leg or foot


• puffiness or swelling of the eyelids or around the eyes


• runny nose


• shortness of breath, troubled breathing, tightness in chest, or wheezing


• skin rash, redness, hives, or itching


• swelling of abdomen or stomach


• uncontrolled bowel movements


• vomiting


• weakness in legs (severe) or problems with moving legs

Other side effects may occur that usually do not need medical attention. Pain and muscle spasms in the lower back may last for several days after you have received chymopapain. Stiffness or soreness in the back may last for several months. Other side effects may go away after a short time. However, check with your doctor if any of the following side effects continue or are bothersome:

More common

• Back pain, stiffness, or soreness


• muscle spasms in lower back

Less common or rare

• Cramps, pain, or mild weakness in legs


• decreased sensitivity to pain


• dizziness


• feeling of burning in lower back


• foot drop


• headache


• nausea


• numbness or tingling in legs or toes

Check with your doctor as soon as possible if any of the following side effects occur:

• Back pain or muscle weakness (sudden and severe)


• skin rash, hives, or itching

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More chymopapain Injection resources

• Chymopapain Injection Support Group
• 0 Reviews · Be the first to review/rate this drug

Hydergine

Generic Name: ergoloid mesylates (ER goe loid MES i lates)

Brand Names: Hydergine

What is Hydergine (ergoloid mesylates)?

Ergoloid mesylates is used to improve cognitive (mental) and self-care functioning in people with symptoms of dementia related to aging or presumed to be related to conditions such as Alzheimer's disease.

Before taking this medication, tell your doctor if you are allergic to any drugs, or if you have circulation problems, high blood pressure, heart disease, or a history of mental illness.

Ergoloid mesylates is not a cure for dementia or for any underlying disease that may lead to decreased mental capacity.

Ergoloid mesylates may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about Hydergine (ergoloid mesylates)?

You should not take this medication if you are allergic to ergoloid mesylates, or if you have a psychotic condition or long-standing mental illness.

This medication will not treat dementia related to mental illness, mood disorders, or neurologic disease.

Call your doctor if you have any changes in memory, alertness, mood, appetite, energy level, or ability to care for yourself.

Your family or other caregivers should also be alert to changes in your mood or symptoms. Your doctor will need to check you at regular visits to make sure ergoloid mesylates is the best treatment for your condition. Do not miss any scheduled appointments.

It may take up to 4 weeks of using this medicine before your symptoms improve. For best results, keep using the medication as directed. Talk with your doctor if your symptoms do not improve after 3 weeks of treatment.

Ergoloid mesylates is not a cure for dementia or for any underlying disease that may lead to decreased mental capacity.

What should I discuss with my healthcare provider before using Hydergine (ergoloid mesylates)?

You should not take this medication if you are allergic to ergoloid mesylates, or if you have a psychotic condition or long-standing mental illness.

Ergoloid mesylates will not treat dementia that is related to mental illness, mood disorders, or neurologic disease.

Before taking ergoloid mesylates, tell your doctor if you are allergic to any drugs, or if you have:

• 
  

  circulation problems;

  
  


• 
  

  high blood pressure;

  
  


• 
  

  heart disease; or

  
  


• 
  

  a history of mental illness.

  
  

If you have any of these conditions, you may need a dose adjustment or special tests to safely take this medication.

Ergoloid mesylates should not be used during pregnancy. Ergoloid mesylates should not be given to a woman who is breast-feeding a baby.

How should I use Hydergine (ergoloid mesylates)?

Take this medication exactly as prescribed by your doctor. Do not take it in larger amounts or for longer than recommended. Follow the directions on your prescription label.

Ergoloid mesylates is usually taken 3 times per day. Follow your doctor's instructions.

Call your doctor if you have any changes in memory, alertness, mood, appetite, energy level, or ability to care for yourself.

Your family or other caregivers should also be alert to changes in your mood or symptoms. Your doctor will need to check you at regular visits to make sure ergoloid mesylates is the best treatment for your condition. Do not miss any scheduled appointments.

It may take up to 4 weeks of using this medicine before your symptoms improve. For best results, keep using the medication as directed. Talk with your doctor if your symptoms do not improve after 3 weeks of treatment. Store ergoloid mesylates at room temperature away from moisture, heat, and light.

What happens if I miss a dose?

Take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine.

Symptoms of an ergoloid mesylates overdose are not known.

What should I avoid while taking Hydergine (ergoloid mesylates)?

Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are taking ergoloid mesylates.

Hydergine (ergoloid mesylates) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Less serious side effects such as nausea or upset stomach are more likely to occur, and you may have no side effects at all.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Hydergine (ergoloid mesylates)?

There may be other drugs that can interact with ergoloid mesylates. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

More Hydergine resources

• Hydergine Side Effects (in more detail)
• Hydergine Use in Pregnancy & Breastfeeding
• Drug Images
• Hydergine Drug Interactions
• Hydergine Support Group
• 0 Reviews for Hydergine - Add your own review/rating

• Hydergine Prescribing Information (FDA)


• Hydergine Advanced Consumer (Micromedex) - Includes Dosage Information


• Hydergine MedFacts Consumer Leaflet (Wolters Kluwer)


• Ergoloid Mesylates MedFacts Consumer Leaflet (Wolters Kluwer)

Compare Hydergine with other medications

• Alzheimer's Disease
• Arteriosclerotic Dementia
• Dementia

Where can I get more information?

• Your pharmacist can provide more information about ergoloid mesylates.

See also: Hydergine side effects (in more detail)

Vitamin B12 Sanum

Vitamin B12 Sanum may be available in the countries listed below.

Ingredient matches for Vitamin B12 Sanum

Cyanocobalamin

Cyanocobalamin is reported as an ingredient of Vitamin B12 Sanum in the following countries:

• Germany

International Drug Name Search

Boots Hayfever and Allergy Relief

Boots Hayfever and Allergy Relief

(Cetirizine Hydrochloride)

Read all of this leaflet carefully because it contains important information for you.

This medicine is available without prescription to treat minor conditions. However, you still need to take it carefully to get the best results from it.

• Keep this leaflet, you may need to read it again


• Ask your pharmacist if you need more information or advice

What this medicine is for

This medicine contains Cetirizine Hydrochloride which belongs to a group of medicines called antihistamines, which act to relieve the symptoms of some allergies.

It can be used to relieve the symptoms of hayfever, year round runny and itchy nose and other allergies such as pet and dust allergies. It can also be used to treat raised, red itchy skin (symptoms of urticaria, which is often known as hives or nettle rash).

Before you take this medicine

This medicine can be taken by adults and children aged 6 years and over. However, some people should not take this medicine or should seek the advice of their pharmacist or doctor first.

Do not take:

• If you are allergic to any of the ingredients (see What is in this medicine)


• If you have an intolerance to some sugars, unless your doctor tells you to (this medicine contains lactose)


• If you are pregnant or breastfeeding

Talk to your pharmacist or doctor:

• If you have kidney problems (you may need to have a smaller amount of this medicine)

Other important information

Driving and using machines: This medicine does not normally cause drowsiness in the majority of people taking it. Therefore it will not normally affect your ability to drive or operate machinery. However, very occasionally some people do report drowsiness or dizziness after taking cetirizine. If affected do not drive or use machines.

Do not drink alcohol (wine, beer, spirits) whilst taking this medicine.

If you take other medicines

This medicine is not expected to affect any other medicines that you may be taking. If you are unsure about interactions with any medicines, talk to your pharmacist. This includes medicines prescribed by your doctor and medicine you have bought for yourself, including herbal and homeopathic remedies.

How to take this medicine

Check the foil is not broken before use. If it is, do not take that tablet.

Adults and children of 6 years and over: Take one tablet once a day.

If you have kidney problems your doctor or pharmacist may advise you to take half of this amount. If this applies to you, follow their instructions.

Swallow the tablet with a drink of water.

Do not give to children under 6 years.

Do not take more than the amount recommended above.

If symptoms do not go away talk to your doctor.

If you take too many tablets: Go to casualty or talk to a doctor straight away. Take your medicine and this leaflet with you.

Possible side effects

Most people will not have problems, but some may get some.

If you get any of these serious side effects, stop taking the tablets. See a doctor at once:

• Difficulty breathing, swelling of the face, neck, tongue or throat (severe allergic reactions)


• Skin rash

These other effects are less serious. If they bother you talk to a pharmacist:

• Headache, agitation


• Dry mouth, upset stomach


• Drowsiness, dizziness


• Very rarely, fits

If any side effect becomes severe, or you notice any side effect not listed here, please tell your pharmacist or doctor.

How to store this medicine

Keep this medicine in a safe place out of the sight and reach of children, preferably in a locked cupboard.

Use by the date on the end flap of the carton. If you still have tablets left return them to your nearest pharmacy for disposal.

What is in this medicine

Each tablet contains Cetirizine Hydrochloride 10 mg which is the active ingredient.

As well as the active ingredient, the tablets also contain microcrystalline cellulose, lactose, colloidal anhydrous silica, magnesium stearate, hypromellose, macrogol, polydextrose, titanium dioxide (E171).

The pack contains 7, 14, 30 or 60 white to off white, film-coated, capsule-shaped tablets. C10 is printed on one side of the tablet and a deep breakline is on the other side.

Packs of 30 and 60 are only available from your pharmacist. Not all pack sizes may be marketed.

Who makes this medicine

Manufactured for The Boots Company PLC by the Marketing Authorisation holder

Galpharm Healthcare Ltd

Dodworth

South Yorkshire

S75 3SP

Leaflet prepared April 2010

If you would like any further information about this medicine, please contact

The Boots Company PLC

Nottingham

NG2 3AA

Other formats

To request a copy of this leaflet in Braille, large print or audio please call, free of charge:

0800 198 5000 (UK only)

Please be ready to give the following information:

Product name: Boots Hayfever and Allergy Relief (7 or 14 tablets)

Reference number: 16028/0067

Product Name: Boots Hayfever and Allergy Relief (30 or 60 tablets)

Reference Number: 16028/0066

This is a service provided by the Royal National Institute of the Blind.

H.G. Metronidazol

H.G. Metronidazol may be available in the countries listed below.

Ingredient matches for H.G. Metronidazol

Metronidazole

Metronidazole is reported as an ingredient of H.G. Metronidazol in the following countries:

• Ecuador

International Drug Name Search

Terbutaline

In some countries, this medicine may only be approved for veterinary use.

In the US, Terbutaline (terbutaline systemic) is a member of the following drug classes: adrenergic bronchodilators, tocolytic agents and is used to treat Asthma - acute, Asthma - Maintenance and Premature Labor.

US matches:

• Terbutaline


• Terbutaline Tablets


• Terbutaline inhalation


• Terbutaline Subcutaneous


• Terbutaline Sulfate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R03AC03,R03CC03

CAS registry number (Chemical Abstracts Service)

0023031-25-6

Chemical Formula

C12-H19-N-O3

Molecular Weight

225

Therapeutic Categories

Antiasthmatic agent

Bronchodilator

ß₂-Sympathomimetic agent

Chemical Name

1,3-Benzenediol, 5-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-

Foreign Names

• Terbutalinum (Latin)
• Terbutalin (German)
• Terbutaline (French)
• Terbutalina (Spanish)

Generic Names

• Terbutalina (OS: DCIT)
• Terbutaline (OS: DCF, BAN)
• Terbutaline Sulfate (OS: JAN, USAN)
• Terbutaline Sulphate (OS: BANM)
• KWD 2019 (IS)
• Terbutaline (sulfate de) (PH: Ph. Eur. 6)
• Terbutaline Sulfate (PH: USP 32, JP XIV)
• Terbutaline Sulphate (PH: BP 2010, Ph. Eur. 6)
• Terbutalini sulfas (PH: Ph. Eur. 6)
• Terbutalinsulfat (PH: Ph. Eur. 6)

Brand Names

• Betanyl
  Unimed, Tunisia



• Bricanyl
  AstraZeneca, Tunisia



• Talin
  Saiph, Tunisia; Simed, Tunisia



• Adrenyl
  UCI, Brazil



• Aerodur Turbohaler
  AstraZeneca, Germany



• Aironyl
  Sedico, Oman; Sedico, Romania



• Alloxygen
  Tynor, Philippines



• Ataline
  Medochemie, Hong Kong; Medochemie, Sri Lanka; Medochemie, Singapore



• Benylin Bronchospect (Terbutaline and Guaifenesin)
  Johnson & Johnson, South Africa



• Brandyl
  CCPC, Taiwan



• Brethine
  AAI, United States



• Bricalin
  Teva, Israel



• Bricanyl Expectorant (Terbutaline and Guaifenesin)
  AstraZeneca, Vietnam



• Bricanyl Respirator
  AstraZeneca, Ireland



• Bricanyl Respules
  AstraZeneca, Ireland



• Bricanyl Retard
  AstraZeneca, Iceland



• Bricanyl SA
  AstraZeneca, Ireland



• Bricanyl Turbohaler
  AstraZeneca, United Arab Emirates; AstraZeneca, Austria; AstraZeneca, Brazil; AstraZeneca, Egypt; AstraZeneca, France; AstraZeneca, United Kingdom; AstraZeneca, Ghana; AstraZeneca, Guyana; AstraZeneca, Ireland; AstraZeneca, Iraq; AstraZeneca, Jordan; AstraZeneca, Kenya; AstraZeneca, Kuwait; AstraZeneca, Lebanon; AstraZeneca, Luxembourg; AstraZeneca, Libya; AstraZeneca, Malawi; AstraZeneca, Mozambique; AstraZeneca, Nigeria; AstraZeneca, Norway; AstraZeneca, New Zealand; AstraZeneca, Oman; AstraZeneca, Portugal; AstraZeneca, Qatar; AstraZeneca, Saudi Arabia; AstraZeneca, Sudan; AstraZeneca, Syria; AstraZeneca, Thailand; AstraZeneca, Tanzania; AstraZeneca, Uganda; AstraZeneca, Yemen; AstraZeneca, Zambia; AstraZeneca, Zimbabwe



• Bricanyl
  AstraZeneca, United Arab Emirates; AstraZeneca, Argentina; AstraZeneca, Austria; AstraZeneca, Australia; AstraZeneca, Belgium; AstraZeneca, Bahrain; AstraZeneca, Burundi; AstraZeneca, Brazil; AstraZeneca, Brazil; AstraZeneca, Canada; AstraZeneca, Switzerland; AstraZeneca, China; AstraZeneca, Czech Republic; AstraZeneca, Germany; AstraZeneca, Denmark; AstraZeneca, Egypt; AstraZeneca, Finland; AstraZeneca, France; AstraZeneca, United Kingdom; AstraZeneca, Georgia; AstraZeneca, Hong Kong; AstraZeneca, Hungary; AstraZeneca, Ireland; AstraZeneca, India; AstraZeneca, Iraq; AstraZeneca, Iceland; AstraZeneca, Italy; AstraZeneca, Jordan; AstraZeneca, Japan; AstraZeneca, Kuwait; AstraZeneca, Lebanon; AstraZeneca, Sri Lanka; AstraZeneca, Luxembourg; AstraZeneca, Libya; AstraZeneca, Malaysia; AstraZeneca, Netherlands; AstraZeneca, Norway; AstraZeneca, Oman; AstraZeneca, Peru; AstraZeneca, Philippines; AstraZeneca, Qatar; AstraZeneca, Reunion; AstraZeneca, Saudi Arabia; AstraZeneca, Sweden; AstraZeneca, Singapore; AstraZeneca, Syria; AstraZeneca, Thailand; AstraZeneca, Turkey; AstraZeneca, Taiwan; AstraZeneca, Vietnam; AstraZeneca, Yemen; AstraZeneca, South Africa; Combiphar, Netherlands; Delphi, Netherlands; EU-Pharma, Netherlands; Euro, Netherlands; IFET, Greece



• Bricanyl (veterinary use)
  AstraZeneca, United Kingdom



• Bricanyl Depot
  AstraZeneca, Norway; AstraZeneca, Sweden



• Bricanyl Turbuhaler
  AstraZeneca, Iceland; AstraZeneca, Peru; AstraZeneca, Sweden



• Bricanyl-Duriles
  AstraZeneca, Germany



• Bricasma Epectorant (Terbutaline and Guaifenesin)
  AstraZeneca, Indonesia



• Bricasma
  AstraZeneca, Indonesia



• Bricasol
  AstraZeneca, China



• Bronclyn
  Medpharma, Oman



• Contimit
  Lindopharm, Germany



• Convon
  Tatsumi Kagaku, Japan



• Dilanyl
  Kuwait Saudi Pharmaceutical Industries Co. - KSPICO, Oman



• Dracanyl Turbuhaler 2care4
  AstraZeneca, Denmark



• Dracanyl Turbuhaler Abacus
  AstraZeneca, Denmark



• Dracanyl Turbuhaler Orifarm
  AstraZeneca, Denmark



• Dracanyl Turbuhaler Singad
  AstraZeneca, Denmark



• Dracanyl
  AstraZeneca, Greece



• Forasma
  Guardian Pharmatama, Indonesia



• Lafayette Terbutaline Sulfate
  Lafayette, Philippines



• Lasmalin
  Lapi Laboratories, Indonesia



• Nairet
  Otto, Indonesia



• Neosma
  Ifars, Indonesia



• Neoterb
  Neopharma, Oman



• Pharmaniaga Terbutaline
  Pharmaniaga, Malaysia



• Pulmobron
  Mugi Laboratories, Indonesia



• Pulmoxcel
  GXI, Philippines



• Relivan
  Novell, Indonesia



• Ritemed Terbutaline
  Ritemed, Philippines



• Sedakter
  Corsa Industries, Indonesia



• Syntovent
  Codal Synto, Sri Lanka



• Tedipulmo
  Estedi, Spain



• Terbasmin Expectorante (Terbutaline and Guaifenesin)
  Ern, Spain



• Terbasmin Turbuhaler 2care4
  AstraZeneca, Denmark



• Terbasmin Turbuhaler Abacus
  AstraZeneca, Denmark



• Terbasmin Turbuhaler Europharma DK
  AstraZeneca, Denmark



• Terbasmin Turbuhaler Singad
  AstraZeneca, Denmark



• Terbasmin Turbuhaler
  AstraZeneca, Spain; D.A.C., Iceland



• Terbasmin
  Ern, Spain



• Terbul
  Hexal, Luxembourg; Teofarma, Germany



• Terbulin
  Vitamed, Israel



• Terburop
  Ropjohn, Ecuador



• Terbutalin AL
  Aliud, Germany



• Terbutaline Arrow
  Arrow, France



• Terbutaline Sulfate
  Akorn, United States; APP, United States; Bedford, United States; Global, United States; Hikma, United States; Impax, United States; Lannett, United States; Teva USA, United States



• Terbutaline
  Akorn, United States; Remedica, Cyprus



• Terbutalin-ratiopharm
  Ratiopharm, Germany



• Tervent
  Unimed & Unihealth, Bangladesh



• Tismalin
  Metiska, Indonesia



• Yarisma
  Yarindo Farmatama, Indonesia

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.